Cancer Cell. 2008 May;13(5):375-6.

A sweet new role for EGFR in cancer.

Source

Massachusetts General Hospital Cancer Center, Boston, MA 02129, USA.

Abstract

The epidermal growth factor (EGFR) has served as an attractive bull's-eye for targeted cancer therapies. Although the importance of EGFR as an oncogenic tyrosine kinase seems well established, a report by Weihua et al. in this issue of Cancer Cell adds a new wrinkle to the role of EGFR in cancer. In this study, the authors demonstrate that EGFR facilitates glucose transport into cells by associating with and stabilizing a sodium/glucose cotransporter (SGLT1). Additionally, they find that this function does not require EGFR kinase activity. These results point to a new kinase-independent role for EGFR in promoting metabolic homeostasis in cancer cells.

Comment on

Cancer Cell. 2008 May;13(5):385-93.

PMID:: 18455118; [PubMed - indexed for MEDLINE]

Publication Types, MeSH Terms, Substances

Publication Types

Comment

MeSH Terms

Substances

LinkOut - more resources

Full Text Sources

Other Literature Sources

COS Scholar Universe

Medical

Cancer - MedlinePlus Health Information

Supplemental Content

Related citations

Survival of cancer cells is maintained by EGFR independent of its kinase activity. [Cancer Cell. 2008]
Survival of cancer cells is maintained by EGFR independent of its kinase activity.
Weihua Z, Tsan R, Huang WC, Wu Q, Chiu CH, Fidler IJ, Hung MC. Cancer Cell. 2008 May; 13(5):385-93.
Vascular endothelial growth factor receptor-1 contributes to resistance to anti-epidermal growth factor receptor drugs in human cancer cells. [Clin Cancer Res. 2008]
Vascular endothelial growth factor receptor-1 contributes to resistance to anti-epidermal growth factor receptor drugs in human cancer cells.
Bianco R, Rosa R, Damiano V, Daniele G, Gelardi T, Garofalo S, Tarallo V, De Falco S, Melisi D, Benelli R, et al. Clin Cancer Res. 2008 Aug 15; 14(16):5069-80. Epub 2008 Aug 11.
Quantum dot-based quantification revealed differences in subcellular localization of EGFR and E-cadherin between EGFR-TKI sensitive and insensitive cancer cells. [Nanotechnology. 2009]
Quantum dot-based quantification revealed differences in subcellular localization of EGFR and E-cadherin between EGFR-TKI sensitive and insensitive cancer cells.
Huang DH, Su L, Peng XH, Zhang H, Khuri FR, Shin DM, Chen ZG. Nanotechnology. 2009 Jun 3; 20(22):225102. Epub 2009 May 12.
Review Strategies for molecular imaging of epidermal growth factor receptor tyrosine kinase in cancer. [J Nucl Med. 2009]
Review Strategies for molecular imaging of epidermal growth factor receptor tyrosine kinase in cancer.
Mishani E, Hagooly A. J Nucl Med. 2009 Aug; 50(8):1199-202. Epub 2009 Jul 17.
Review Potential for molecularly targeted therapy against epidermal growth factor receptor ligands. [Anticancer Res. 2009]
Review Potential for molecularly targeted therapy against epidermal growth factor receptor ligands.
Miyamoto S, Fukami T, Yagi H, Kuroki M, Yotsumoto F. Anticancer Res. 2009 Mar; 29(3):823-30.

See reviews... See all...

Cited by 4 PubMed Central articles

HDAC inhibition decreases the expression of EGFR in colorectal cancer cells. [PLoS One. 2011]
HDAC inhibition decreases the expression of EGFR in colorectal cancer cells.
Chou CW, Wu MS, Huang WC, Chen CC. PLoS One. 2011 Mar 25; 6(3):e18087. Epub 2011 Mar 25.
Proteomic snapshot of the EGF-induced ubiquitin network. [Mol Syst Biol. 2011]
Proteomic snapshot of the EGF-induced ubiquitin network.
Argenzio E, Bange T, Oldrini B, Bianchi F, Peesari R, Mari S, Di Fiore PP, Mann M, Polo S. Mol Syst Biol. 2011 Jan 18; 7:462.
EGFR signaling through an Akt-SREBP-1-dependent, rapamycin-resistant pathway sensitizes glioblastomas to antilipogenic therapy. [Sci Signal. 2009]
EGFR signaling through an Akt-SREBP-1-dependent, rapamycin-resistant pathway sensitizes glioblastomas to antilipogenic therapy.
Guo D, Prins RM, Dang J, Kuga D, Iwanami A, Soto H, Lin KY, Huang TT, Akhavan D, Hock MB, et al. Sci Signal. 2009 Dec 15; 2(101):ra82. Epub 2009 Dec 15.

See all...

Related information

Related Citations
Calculated set of PubMed citations closely related to the selected article(s) retrieved using a word weight algorithm. Related articles are displayed in ranked order from most to least relevant, with the “linked from” citation displayed first.
Cited in PMC
Full-text articles in the PubMed Central Database that cite the current articles.

Recent activity

Clear Turn Off Turn On

A sweet new role for EGFR in cancer.
A sweet new role for EGFR in cancer.
Cancer Cell. 2008 May ;13(5):375-6.

PubMed
Nutlin-3a activates p53 to both down-regulate inhibitor of growth 2 and up-regul...
Nutlin-3a activates p53 to both down-regulate inhibitor of growth 2 and up-regulate mir-34a, mir-34b, and mir-34c expression, and induce senescence.
Cancer Res. 2008 May 1 ;68(9):3193-203.

PubMed
Intrinsic resistance of tumorigenic breast cancer cells to chemotherapy.
Intrinsic resistance of tumorigenic breast cancer cells to chemotherapy.
J Natl Cancer Inst. 2008 May 7 ;100(9):672-9. Epub 2008 Apr 29 .

PubMed
Akt3 and mutant V600E B-Raf cooperate to promote early melanoma development.
Akt3 and mutant V600E B-Raf cooperate to promote early melanoma development.
Cancer Res. 2008 May 1 ;68(9):3429-39.

PubMed
Traditional Chinese acupuncture and placebo (sham) acupuncture are differentiate...
Traditional Chinese acupuncture and placebo (sham) acupuncture are differentiated by their effects on mu-opioid receptors (MORs).
Neuroimage. 2009 Sep ;47(3):1077-85. Epub 2009 Jun 6 .

PubMed

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

PubMed

Display Settings:

Send to: